Open AccessS282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID‐19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION
Author(s) -
MüllerTidow C.,
Janssen M.,
Schäkel U.,
Gall J.,
Leo A.,
Stelmach P.,
Krisam J.,
Baumann L.,
Stermann J.,
Merle U.,
Zeier M.,
Weigand M. A.,
Bullinger L.,
Schrezenmeier J.F.,
Bornhäuser M.,
Alakel N.,
Witzke O.,
Wolf T.,
Vehreschild M. J.,
Schmiedel S.,
Addo M. M.,
Herth F.,
Kreutner M,
Tepasse P.R.,
Hertenstein B.,
Hänel M.,
Morgner A.,
Kiehl M.,
Hopfer O.,
Wattad M.A.,
Schimanski C. C.,
Celik C,
Pohle T.,
Ruhe M.,
Kern W. V.,
Schmitt A,
Schmitt M.,
Dreger P.,
Lorenz H.M.,
SoutoCarneiro M.,
Halama N.,
Meuer S.,
Kräusslich H.G.,
Müller B.,
Bartenschlager R.,
Klemmer J.,
Kriegsmann K.,
Schlenk R. F.,
Denkinger C. M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844020.02619.0f
Subject(s) - medicine , immunosuppression , clinical endpoint , randomized controlled trial , vaccination , adverse effect , clinical trial , immunology